|
|||
|
DRUGS & SUPPLEMENTS
|
Gaboton
How long you have been taking the medicine? |
Gaboton uses
Pharmacological action
Gaboton is an antiepileptic drug. Chemical structure is similar to GABA fulfilling the function of the inhibitory neurotransmitter in the CNS. It is believed that the mechanism of action of Gaboton is different from other anticonvulsants acting through GABA synapses. In in vitro studies showed that Gaboton is characterized by the presence of a new peptide binding sites in the brain tissues of rats, including the hippocampus and cerebral cortex, which may be relevant to the anticonvulsant activity of Gaboton and its derivatives. Gaboton in clinically relevant concentrations is not associated with other conventional drugs and neurotransmitter receptors in the brain.
The final mechanism of action of Gaboton is not defined.
Pharmacokinetics
Gaboton is absorbed from the gastrointestinal tract. After oral administration of Gaboton Cmax in plasma achieved within 2-3 hours. The absolute bioavailability of approximately 60%. Taking of this medication in conjunction with food (including a high-fat) does not affect the pharmacokinetics of Gaboton.
Gaboton is not bound to plasma proteins and has Vd 57.7 l.
Gaboton is excreted only by the kidneys. Signs of biotransformation of Gaboton in the human body were not found.
Gaboton is removed from plasma by hemodialysis.
The concentrations of Gaboton in the plasma of children were similar to those of adults.
Why is Gaboton prescribed?
Treatment of neuropathic pain in adults over the age of 18 years; monotherapy of partial seizures with secondary generalization and without its fot children and adults older than 12 years; as an adjunct in the treatment of partial seizures with secondary generalization and without its for adults and children aged 3 years and older.
Dosage and administration
Dosing regimen of Gaboton is individual, depending on the indications and treatment regimens.
Gaboton side effects, adverse reactions
CNS and peripheral nervous system: amnesia, ataxia, confusion, impaired coordination, depression, dizziness, dysarthria, nervous hyperexcitability, nystagmus, drowsiness, impaired thinking, tremor, muscle cramps, amblyopia, diplopia, hyperkinesia, strengthening, weakening or absence of reflexes, paresthesia, anxiety, hostility, impaired gait.
Digestive system: change in staining of teeth, diarrhea, increased appetite, dry mouth, nausea, vomiting, flatulence, anorexia, gingivitis, abdominal pain, pancreatitis, changes in liver function tests.
Hemopoietic system: leucopenia, decrease the number of leukocytes, thrombocytopenic purpura.
Respiratory system: rhinitis, pharyngitis, cough, pneumonia.
Musculoskeletal system: myalgia, arthralgia, bone fractures.
Cardiovascular: hypertension, manifestations of vasodilation.
Urinary system: urinary tract infections, urinary incontinence.
Allergic reactions: erythema multiforme, Stevens-Johnson syndrome.
Dermatological reactions: maceration of the skin, acne, itching, rash.
Other: back pain, fatigue, peripheral edema, impotence, fatigue, malaise, swelling of the face, increase in body weight, accidental injury, asthenia, flu-like syndrome, fluctuations in blood glucose in children - a viral infection, otitis media.
Gaboton contraindications
Hypersensitivity to Gaboton.
Using during pregnancy and breastfeeding
Adequate and well-controlled studies on the safety of Gaboton during pregnancy and lactation in humans has not been conducted. If necessary use Gaboton during pregnancy and lactation patients should carefully weigh the potential benefits of therapy for the mother and the potential risk to the fetus or infant.
Gaboton is excreted in breast milk. When this drug used in the lactation period, the character of the action of Gaboton on the infant is not defined.
Category effects on the fetus by FDA - C.
Special instructions
Abrupt discontinuation of therapy by anticonvulsant drugs in patients with partial seizures may provoke a convulsive status. If necessary to reduce the dose of Gaboton, to cancel or replace it with an alternative means it should be phased over a minimum of 1 week.
Gaboton is not an effective drug for treatment of absence seizures.
For patients with impaired renal function and patients in hemodialysis it requires correction of dosing regimen. Elderly patients may require correction of the dosing regimen of Gaboton due to the fact that such patients may decrease renal clearance.
The efficacy and safety of neuropathic pain treatment in patients under age 18 is not defined.
During the period of treatment it is necessary to avoid taking alcohol.
Prior to determining individual response to treatment the patient should refrain from potentially dangerous activities coupled with the need to focus and improve the speed of psychomotor reactions.
Gaboton drug interactions
Simultaneous administration of Gaboton with:
Gaboton in case of emergency / overdose
There was reported an acute overdose while taking 49 g of Gaboton. Symptoms: double vision, slurred speech, drowsiness, lethargy, diarrhea.
Treatment: maintenance therapy, hemodialysis.
Gaboton pharmaceutical active ingredients containing related brand and generic drugs:
Gaboton available forms, composition, doses:
Composition is the list of ingredients which combinedly form a medicine. Both active ingredients and inactive ingredients form the composition. The active ingredient gives the desired therapeutic effect whereas the inactive ingredient helps in making the medicine stable.
Doses are various strengths of the medicine like 10mg, 20mg, 30mg and so on. Each medicine comes in various doses which is decided by the manufacturer, that is, pharmaceutical company. The dose is decided on the severity of the symptom or disease.